Blog dedicated to the continuous education in Gynecology and Endocrinology


• October, 2011 •


Dear GynEndocrinologists,
A fall in October is finally here. Some might say… Well at last! It is true: we had a very strange Fall here in old Europe: beautiful days, hot temperatures and a great summer which seems to be a neverending one. But what the heck… what luck! Who prefers wet and freezing experiences to sunny and gorgeous days? Indeed we should have a great year of wine and Nature makes this life more joyful and loving. Yes, because … for the rest, the World economy is making headway towards the abyss. In a society where everything seems to be available handy, we awaken to the future with uncertainty and fear for our children: can we guarantee to them the same stability and peace that we had when we were young? more

Post to Twitter Post to Facebook

• August, 2010 •


Like every month, here we are with you to follow those who in the upper half of our earth die in the heat of Summer and to cheer up those who in the lower half sit in the midst of their cold Winter. The black oily spill from the Deepwater Horizon platform has been finally stopped, and this is something that will also comfort all those who happen to live in the areas where damage was done. Many years will have to pass by before Mother Nature will find the way back to normality out of this mess. more

Post to Twitter Post to Facebook

Suggested Readings

  1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Fertil Steril. 2004 Jan;81(1):19-25.
  2. ACOG Practice Bulletin No. 108: Polycystic ovary syndrome. ACOG Committee on Practice Bulletins–Gynecology. Obstet Gynecol. 2009 Oct;114(4):936-49.
  3. Screening women with polycystic ovary syndrome for metabolic syndrome. Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia DH. Obstet Gynecol. 2005 Jul;106(1):131-7.
  4. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. BJOG. 2006 Oct;113(10):1210-7.
  5. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
  6. Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ. Hum Reprod. 2009 Mar;24(3):710-7. Epub 2008 Dec 17.
  7. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Moran LJ, Misso ML, Wild RA, Norman RJ. Hum Reprod Update. 2010 Jul-Aug;16(4):347-63. Epub 2010 Feb 16.
  8. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. Ridker PM, Buring JE, Rifai N, Cook NR. JAMA. 2007 Feb 14;297(6):611-9. Erratum in: JAMA. 2007 Apr 4;297(13):1433.
  9. Patient-tailored conventional ovulation induction algorithms in anovulatory infertility. van Santbrink EJ, Eijkemans MJ, Laven JS, Fauser BC. Trends Endocrinol Metab. 2005 Oct;16(8):381-9. Review.
  10. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. Hum Reprod Update. 2006 Nov-Dec;12(6):673-83. Epub 2006 Aug 4. Review.
  11. Consensus on infertility treatment related to polycystic ovary syndrome. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Hum Reprod. 2008 Mar;23(3):462-77. Erratum in: Hum Reprod. 2008 Jun;23(6):1474.

    Post to Twitter Post to Facebook

    • July, 2010 •

    Waka waka waka..

    Waka waka waka, one could say! Yes, some of us are from Europe, some from America, some from Asia but everybody knows what happened in South Africa: the FIFA World Championship! Or, given the final result: “el Mundial”. Shakira’s song sang all day long and even if we think only at Gynecological Endocrinology, well something happened out of here… this was Soccer Time! During these exciting days soccer players fought for the Cup and we were all with them, in South Africa! But how many surprises!! The two former finalists, Italy and France were eliminated first, then the Old South American schools: Brazil and Argentina.

    It’s somehow like what we experience in our daily hormonal practice, when you expect something often you realize the problem is entirely different or at least more complex than it seemed in the beginning. And at the end of the day, the doctor who wins needs to be the best and the more complete, like Spain! This is why it is so important that we all get our periodical professional update, and what is best that receiving it for free and directly at your own home? Today we present you two great lessons from the ISGRE (the educational branch of ISGE) school courses held in Florence before the 14th ISGE World Congress by Prof. David Baird and Prof. Felice Petraglia. Both will discuss the non-contraceptive use of hormonal contraceptive formulations and their advantages and indications in the treatment of frequent gynecologic diseases that are often difficult to approach: dysfunctional uterine bleedings, dysmenorrhea, fibroids, endometriosis and functional ovarian cysts. The speakers present all the data available so far, focusing on the latest Cochrane reviews.

    We thus have a tremendous opportunity to refresh our knowledge about these common diseases and to decide the most correct management by the commodity of our office. We added some important references to study in deep each presentation. As every month, we also provide access to some of the most exciting presentations from the 14th ISGE World Congress on Gynecological Endocrinology. The topics are quite various: contraceptives and ovulation, endometriosis and abortion, we are sure you will love them … But mostly, our powerful Internet-based technology will make the magic of bringing the speakers you always wanted to listen, directly to the comfort of your office or home.

    Enjoy the presentations, GynEndocrinologists and … Waka waka waka!

    Post to Twitter Post to Facebook

    Suggested readings

    1. Reconsidering menorrhagia in gynecological practice. Is a 30-year-old definition still valid? Janssen CA, Scholten PC, Heintz AP. Eur J Obstet Gynecol Reprod Biol. 1998 May;78(1):69-72.
    2. NICE says hysterectomy must be last option for heavy menstrual bleeding. Mayor S. BMJ. 2007 Jan 27;334(7586):175.
    3. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Andersson JK, Rybo G. Br J Obstet Gynaecol. 1990 Aug;97(8):690-4.
    4. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation. Hickey M, Higham J, Fraser IS. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD001895.
    5. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Marjoribanks J, Proctor M, Farquhar C, Derks RS. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD001751.
    6. Danazol for uterine fibroids. Ke LQ, Yang K, Li J, Li CM. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007692.
    7. Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications. Rodriguez MI, Warden M, Darney PD. Am J Obstet Gynecol. 2010 May;202(5):420-8.
    8. Noncontraceptive health benefits of combined oral contraception. ESHRE Capri Workshop Group. Hum Reprod Update. 2005 Sep-Oct;11(5):513-25.
    9. Cochrane Update. Oral contraceptives for functional ovarian cysts. Obstet Gynecol. 2009 Sep;114(3):679-80.
    10. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Allen C, Hopewell S, Prentice A, Gregory D.
    11. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004753. Review.
    12. Progestogens for endometriosis: forward to the past. Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG. Hum Reprod Update. 2003 Jul-Aug;9(4):387-96.

    Post to Twitter Post to Facebook

    © International Society of Gynecological Endocrinology - Privacy Policy